(Q44350696)

2 December 2017

title

Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor (English)

1 reference

2 December 2017

0 references

Williams KL

1

1 reference

2 December 2017

Woods JH

series ordinal

2

1 reference

2 December 2017

publication date

1 November 1998

1 reference

Alcoholism: Clinical and Experimental Research

2 December 2017

published in

1 reference

2 December 2017

volume

22

1 reference

2 December 2017

issue

8

1 reference

2 December 2017

page(s)

1634-1639

1 reference

Naltrexone in the treatment of alcohol dependence

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Effect of naltrexone on alcohol "high" in alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Genetics of alcoholism: role of the endogenous opioid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Opiate receptor binding affected differentially by opiates and opioid peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Radioligands for Probing Opioid Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Importance of delta opioid receptors in maintaining high alcohol drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Clocinnamox antagonism of opioid suppression of schedule-controlled responding in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Endorphins and food intake: kappa opioid receptor agonists and hyperphagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Kappa-opioid antagonist strongly attenuates drinking of genetically polydipsic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1530-0277.1998.TB03960.X

10.1111/J.1530-0277.1998.TB03960.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference